Drug Type Stem cell therapy |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Aniridia | Phase 2 | BE | 30 Apr 2015 | |
Blindness | Phase 2 | BE | 30 Apr 2015 | |
Keratitis | Phase 2 | BE | 30 Apr 2015 | |
Corneal Diseases | Phase 2 | CN | 01 Dec 2012 | |
Hyperopia | Phase 2 | CN | 01 Dec 2012 | |
Myopia | Phase 2 | CN | 01 Dec 2012 | |
Pterygium | Phase 2 | CN | 01 Dec 2012 | |
Limbal stem cell deficiency | Phase 2 | IR | 31 Oct 2007 | |
Limbal stem cell deficiency | Phase 2 | IR | 31 Oct 2007 | |
Photophobia | Phase 2 | IR | 31 Oct 2007 |